Bank of America’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-330,000
| Closed | -$33.1M | – | 8433 |
|
|
2025
Q3 | $33.1M | Buy |
330,000
+80,000
| +32% | +$7.21M | ﹤0.01% | 2118 |
|
|
2025
Q2 | $20.7M | Sell |
250,000
-387,200
| -61% | -$30.9M | ﹤0.01% | 2521 |
|
|
2025
Q1 | $51.7M | Sell |
637,200
-622,800
| -49% | -$55.7M | ﹤0.01% | 1551 |
|
|
2024
Q4 | $113M | Buy |
1,260,000
+510,000
| +68% | +$49.4M | 0.01% | 955 |
|
|
2024
Q3 | $74.1M | Sell |
750,000
-727,600
| -49% | -$71.5M | 0.01% | 1263 |
|
|
2024
Q2 | $137M | Sell |
1,477,600
-564,100
| -28% | -$50.6M | 0.01% | 856 |
|
|
2024
Q1 | $194M | Buy |
2,041,700
+673,400
| +49% | +$62.5M | 0.02% | 702 |
|
|
2023
Q4 | $122M | Buy |
1,368,300
+200,800
| +17% | +$14.9M | 0.01% | 855 |
|
|
2023
Q3 | $85.3M | Sell |
1,167,500
-2,027,300
| -63% | -$162M | 0.01% | 971 |
|
|
2023
Q2 | $266M | Buy |
3,194,800
+2,184,900
| +216% | +$183M | 0.03% | 502 |
|
|
2023
Q1 | $77M | Buy |
1,009,900
+75,000
| +8% | +$6.22M | 0.01% | 1090 |
|
|
2022
Q4 | $77.6M | Buy |
934,900
+234,200
| +33% | +$19M | 0.01% | 1028 |
|
|
2022
Q3 | $55.6M | Sell |
700,700
-399,300
| -36% | -$33.7M | 0.01% | 1188 |
|
|
2022
Q2 | $81.7M | Buy |
1,100,000
+514,700
| +88% | +$38.6M | 0.01% | 993 |
|
|
2022
Q1 | $52.6M | Sell |
585,300
-933,500
| -61% | -$86.2M | 0.01% | 1330 |
|
|
2021
Q4 | $170M | Buy |
1,518,800
+1,264,600
| +497% | +$153M | 0.02% | 746 |
|
|
2021
Q3 | $32M | Sell |
254,200
-629,200
| -71% | -$81M | ﹤0.01% | 1719 |
|
|
2021
Q2 | $120M | Buy |
883,400
+873,000
| +8,394% | +$115M | 0.01% | 857 |
|
|
2021
Q1 | $1.41M | Sell |
10,400
-667,600
| -98% | -$100M | ﹤0.01% | 4533 |
|
|
2020
Q4 | $95.4M | Buy |
678,000
+331,700
| +96% | +$42.5M | 0.01% | 820 |
|
|
2020
Q3 | $38.6M | Buy |
346,300
+21,300
| +7% | +$2.39M | 0.01% | 1236 |
|
|
2020
Q2 | $36.4M | Sell |
325,000
-45,200
| -12% | -$4.45M | 0.01% | 1196 |
|
|
2020
Q1 | $28.7M | Buy |
+370,200
| New | +$32.8M | 0.01% | 1268 |
|
|
2019
Q4 | – | Sell |
-957,000
| Closed | -$73M | – | 7442 |
|
|
2019
Q3 | $73M | Buy |
957,000
+765,200
| +399% | +$63.6M | 0.01% | 903 |
|
|
2019
Q2 | $16.8M | Sell |
191,800
-188,000
| -49% | -$16M | ﹤0.01% | 2025 |
|
|
2019
Q1 | $34.4M | Sell |
379,800
-440,200
| -54% | -$37.4M | 0.01% | 1391 |
|
|
2018
Q4 | $58.8M | Buy |
820,000
+683,000
| +499% | +$55M | 0.01% | 910 |
|
|
2018
Q3 | $13.1M | Sell |
137,000
-699,500
| -84% | -$67.8M | ﹤0.01% | 2190 |
|
|
2018
Q2 | $79.6M | Buy |
836,500
+830,100
| +12,970% | +$76.3M | 0.01% | 798 |
|
|
2018
Q1 | $561K | Sell |
6,400
-1,108,200
| -99% | -$101M | ﹤0.01% | 4741 |
|
|
2017
Q4 | $94.6M | Buy |
1,114,600
+1,053,400
| +1,721% | +$88.2M | 0.02% | 757 |
|
|
2017
Q3 | $5.3M | Buy |
61,200
+59,200
| +2,960% | +$4.75M | ﹤0.01% | 3129 |
|
|
2017
Q2 | $154K | Sell |
2,000
-753,900
| -100% | -$53.5M | ﹤0.01% | 5426 |
|
|
2017
Q1 | $52.4M | Buy |
755,900
+659,700
| +686% | +$44.3M | 0.01% | 1013 |
|
|
2016
Q4 | $5.69M | Buy |
96,200
+96,000
| +48,000% | +$5.93M | ﹤0.01% | 2808 |
|
|
2016
Q3 | $13K | Sell |
200
-400
| -67% | -$24.7K | ﹤0.01% | 6299 |
|
|
2016
Q2 | $32K | Sell |
600
-202,800
| -100% | -$11.1M | ﹤0.01% | 6038 |
|
|
2016
Q1 | $10.5M | Buy |
203,400
+33,500
| +20% | +$1.74M | ﹤0.01% | 2102 |
|
|
2015
Q4 | $11.9M | Sell |
169,900
-100,300
| -37% | -$6.84M | ﹤0.01% | 2112 |
|
|
2015
Q3 | $16.8M | Buy |
270,200
+120,200
| +80% | +$9.47M | ﹤0.01% | 1752 |
|
|
2015
Q2 | $12.6M | Buy |
+150,000
| New | +$11.7M | ﹤0.01% | 1734 |
|
|
2014
Q3 | – | Sell |
-22,500
| Closed | -$1.16M | – | 8201 |
|
|
2014
Q2 | $1.16M | Buy |
+22,500
| New | +$1.01M | ﹤0.01% | 3869 |
|
Other funds holding XBI
JFG
Bank of America's XBI Position: Q1 2026 in Review
Bank of America increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, buying an estimated $212M and bringing the position to 14,518,027 shares worth $1.85B. The position accounts for 0.14% of the portfolio, ranked #161.
Bank of America first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Bank of America held 14,518,027 shares of State Street SPDR S&P Biotech ETF worth $1.85B as of Q1 2026.
- Bank of America bought 1,700,851 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $212M.
- State Street SPDR S&P Biotech ETF made up 0.14% of Bank of America's portfolio in Q1 2026, its #161 holding.
- Bank of America first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.